R
Rea Andermatt
Researcher at University of Zurich
Publications - 11
Citations - 4921
Rea Andermatt is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 3243 citations.
Papers
More filters
Journal ArticleDOI
Endothelial cell infection and endotheliitis in COVID-19.
Zsuzsanna Varga,Andreas J. Flammer,Peter Steiger,Martina Haberecker,Rea Andermatt,Annelies S. Zinkernagel,Mandeep R. Mehra,Reto A. Schuepbach,Frank Ruschitzka,Holger Moch +9 more
TL;DR: The vascular endothelium is an active paracrine, endocrine, and Endothelial cell infection and endotheliitis in COVID-19 and recruitment of immune cells can result in widespread endothelial dysfunction associated with apoptosis.
Journal ArticleDOI
Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
Zsuzsanna Varga,Andreas J. Flammer,Peter Steiger,Martina Haberecker,Rea Andermatt,Annelies S. Zinkernagel,Mandeep R. Mehra,Felix Scholkmann,Reto Schüpbach,Frank Ruschitzka,Holger Moch +10 more
Journal ArticleDOI
Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome
Pedro D. Wendel-García,Rolf Erlebach,Daniel A. Hofmaenner,Giovanni Camen,Reto A. Schuepbach,Christoph Jüngst,Beat Müllhaupt,Jan Bartussek,Philipp K. Buehler,Rea Andermatt,Sascha David +10 more
TL;DR: In this article , the authors investigated a potential dose-response relationship between ketamine and bilirubin levels and showed a causally plausible, dose-effect relationship between long-term infusion of ketamine, as well as an augmented, ketamine-associated, hazard of cholestatic liver injury in critically ill COVID-19 patients could be shown.
Journal ArticleDOI
Elimination of Herpes Simplex Virus-2 and Epstein-Barr Virus With Seraph 100 Microbind Affinity Blood Filter and Therapeutic Plasma Exchange: An Explorative Study in a Patient With Acute Liver Failure
Rea Andermatt,Guido V. Bloemberg,Christoph C. Ganter,Nicolas J. Mueller,Antonia Ms Mueller,Beat Muellhaupt,Jan T. Kielstein,Sascha David +7 more
TL;DR: Seraph seemed to be far more effective of removing EBV, implicating a possible use in EBV-associated pathologies, but this requires further study.
Journal ArticleDOI
[OCT, Triple H or anything else?]
TL;DR: In this paper , a 25-jährigen Patientin mit Hyperammonämie is described, and the Relevanz der extrakorporalen Elimination des Ammoniaks is discussed.